Results 41 to 50 of about 1,820,346 (284)

NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy [PDF]

open access: yes, 2013
Alzheimer’s disease (AD) is a devastating neurodegenerative disease causing irreversible cognitive decline in the elderly. There is no disease-modifying therapy for this condition and the mechanisms underpinning neuronal dysfunction and neurodegeneration
Cowan, C.M., Mudher, A., Quraishe, S.
core   +1 more source

Developmental Disorders in Children Recently Diagnosed With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Neurocognitive deficits in adult survivors of childhood cancer are well established, but less is known about developmental disorders (DD) arising shortly after cancer diagnosis. Using 2016–2019 linked Ohio cancer registry and Medicaid data, we compared DD among 324 children with cancer and 606,913 cancer‐free controls.
Jamie Shoag   +5 more
wiley   +1 more source

Modifying Coatings for Medical Implants Made of Titanium Alloys

open access: yesMetals, 2023
This review considered various methods for depositing special modifying coatings on medical implants made of titanium alloys including techniques such as electrochemical deposition, sol–gel process, atmospheric plasma deposition, and PVD methods ...
Sergey Grigoriev   +4 more
doaj   +1 more source

Achieving Obfuscation Through Self-Modifying Code: A Theoretical Model [PDF]

open access: yes, 2020
With the extreme amount of data and software available on networks, the protection of online information is one of the most important tasks of this technological age.
Waddell, Heidi
core   +1 more source

Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background B‐acute lymphoblastic leukemia (B‐ALL) is the most common pediatric cancer, and while most children in high‐resource settings are cured, therapy carries risks for long‐term toxicities. Understanding parents’ concerns about these late effects is essential to guide anticipatory support and inform evolving therapeutic approaches ...
Kellee N. Parker   +7 more
wiley   +1 more source

MODIFYING OF SECONDARY ALLOYS

open access: yesЛитьë и металлургия, 2015
It is shown that impurity modifying of secondary alloys inefficiently because of the high contents in fusion of high-disperse nonmetallic particles. They promote receiving not modified microstructure and pollution of castings by nonmetallic inclusions ...
V. Yu. Stetsenko
doaj  

Disease modifying therapy for multiple system atrophy – Parkinsonian Type [PDF]

open access: yes, 2017
BACKGROUND: Multiple System Atrophy –Parkinsonian Type (MSA-P) is a rare, rapidly progressive neurodegenerative disease without any current treatment.
Dwyer, Sean Sullivan
core  

Modifying surfaces in 4-manifolds by twist spinning

open access: yes, 2009
In this paper, given a knot K, for any integer m we construct a new surface Sigma_K(m) from a smoothly embedded surface Sigma in a smooth 4-manifold X by performing a surgery on Sigma.
Fintushel   +12 more
core   +1 more source

Clinical Characteristics and Prognostic Risk Factors for Pediatric B‐Cell Lymphoblastic Lymphoma: A Multicenter Retrospective Cohort Study for China Net Childhood Lymphoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background B‐cell lymphoblastic lymphoma (B‐LBL) represents a rare variety of non‐Hodgkin lymphoma, with limited research on its biology, progression, and management. Methods A retrospective analysis was performed on the clinical characteristics of 256 patients aged ≤18 years who received treatment under the China Net Childhood Lymphoma (CNCL)‐
Zhijuan Liu   +20 more
wiley   +1 more source

Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies [PDF]

open access: yes, 2015
Multiple sclerosis is a demyelinating disease affecting the central nervous system. It is the most prevalent disabling neurological condition among young adults, with onset typically between 20 and 40 years of age. Infiltrating immune cells and microglia
Kay, Kathleen Alexandra
core   +1 more source

Home - About - Disclaimer - Privacy